These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25818768)

  • 1. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore.
    Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS
    Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy.
    Pieroni M; Machado D; Azzali E; Santos Costa S; Couto I; Costantino G; Viveiros M
    J Med Chem; 2015 Aug; 58(15):5842-53. PubMed ID: 26197353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
    Dixit PP; Dixit PP; Thore SN
    Eur J Med Chem; 2016 Jan; 107():38-47. PubMed ID: 26562541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
    Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activities of novel fluoroquinolones.
    Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
    Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
    J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
    Mahajan NS; Dhawale SC
    Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.
    Fomogne-Fodjo MC; Ndinteh DT; Olivier DK; Kempgens P; van Vuuren S; Krause RW
    J Ethnopharmacol; 2017 Jan; 195():238-245. PubMed ID: 27864111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
    Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
    J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.